A life-saving kind of technology
At McGill University, researchers have found a way to work with the body's own blood to engineer clots that far surpass what nature produces alone — a discovery that reframes the ancient problem of uncontrolled bleeding not as a biological limit, but as an engineering challenge now within reach of solution. Published in Nature, the technique called click clotting compresses the body's five-minute clotting process into mere seconds, offering trauma and surgical teams a tool that could tip the balance between survival and loss in the moments that matter most. It is a reminder that some of medicine's most profound advances come not from replacing the body, but from learning to amplify what it already knows how to do.
- Every year, severe bleeding claims lives in trauma bays and operating rooms simply because the body's natural clotting process is too slow and too fragile to keep pace with catastrophic injury.
- McGill's click clotting technique creates engineered clots 13 times more resistant to breaking apart and 4 times more adhesive than natural ones — numbers that represent a fundamental leap, not an incremental improvement.
- The engineered clots can halt bleeding in seconds rather than the five minutes natural clotting requires, with preparation taking only 10 to 20 minutes using patient or donor blood.
- Earlier attempts to improve clotting with shellfish-derived materials collapsed under problems of fragility, cell breakdown, and environmental concerns — click clotting sidesteps all of these by working within the patient's own biology.
- The technology is now positioned to reshape emergency and surgical medicine, with liver injury treatment already demonstrating standout results in one of trauma care's most difficult bleeding scenarios.
Researchers at McGill University have developed a technique called click clotting that engineers blood clots dramatically stronger and more adhesive than those the body forms on its own. Published in Nature, the work represents a meaningful shift in how scientists understand clotting at the molecular level — discovering that red blood cells, when properly engineered through a targeted chemical reaction, can serve as the structural foundation for clots that far outperform nature's version.
The performance gap is striking. Click clots are 13 times more resistant to breaking apart and four times more adhesive than natural clots, and they can stop bleeding in seconds rather than the five minutes natural clotting typically requires. A patient's own blood takes about 20 minutes to prepare; matched donor blood can be processed in roughly 10.
Senior researcher Jianyu Li framed the problem plainly: natural clots form slowly and remain mechanically fragile, often failing under the pressure of severe injury and interfering with healing. The team's approach builds on — and corrects — earlier efforts using chitosan, a shellfish-derived material that proved too fragile and raised environmental concerns. Click clotting avoids foreign materials entirely, working with the patient's own biology instead.
In testing, the technique showed particular promise in liver injuries, among the most difficult bleeding scenarios in trauma medicine. For surgeons and trauma teams working in environments where seconds determine survival, a clot that forms almost instantly and holds together far more reliably than a natural one is not a refinement — it is a transformation of what becomes possible when time is the scarcest resource.
A team of researchers at McGill University has developed a method to stop severe bleeding faster than the body's natural process allows. The technique, which they call click clotting, uses a chemical reaction applied to a person's own blood or matched donor blood to engineer clots that are dramatically stronger and stickier than those that form on their own.
The findings, published last month in Nature, represent a significant shift in how scientists think about blood clotting at the molecular level. Rather than waiting for the body's slower, more fragile clotting cascade to do its work, the McGill team discovered that red blood cells, when engineered properly, can serve as the structural foundation for biomaterials that perform far better than nature's version. The journal's accompanying commentary described the approach as cells snapped together to seal wounds.
The numbers tell the story of the improvement. Clots created through click clotting proved 13 times more resistant to breaking apart and four times more adhesive than naturally formed clots. Perhaps more importantly, the engineered clots can stop bleeding in seconds—a dramatic compression of the five minutes it typically takes for natural clotting to achieve the same result. A patient's own blood takes about 20 minutes to prepare into a click clot; donor blood can be processed in roughly 10 minutes.
Jianyu Li, the senior researcher leading the work, explained the problem the team set out to solve. Natural blood clots form slowly and remain mechanically fragile, which means they often fail to contain severe bleeding and can interfere with proper healing. By engineering red blood cells to play a central structural role, Li's team created clots that don't just match nature's performance—they exceed it substantially. In testing, the engineered approach showed particular promise in stopping liver injuries, one of the most challenging bleeding scenarios in trauma medicine.
This breakthrough builds on earlier attempts to improve clotting using chitosan, a material derived from shellfish waste. Those efforts foundered because the resulting clots were too fragile, cells broke down unpredictably, and the chemical processes involved created pollution concerns that offset the sustainability gains. The click clotting approach sidesteps these problems by working with the patient's own biology rather than introducing foreign materials.
In the high-pressure environment of a trauma bay or operating room, where minutes—sometimes seconds—determine whether a patient survives, this technology could reshape outcomes. When a surgeon or trauma team can deploy a clot that forms in seconds rather than minutes, and holds together far more reliably than a natural clot, the difference becomes a matter of life and death. Li told reporters that the ability to stop bleeding quickly is fundamentally a life-saving technology, one that transforms what's possible when time is the scarcest resource.
Notable Quotes
Natural blood clots can be slow to form and mechanically fragile, which limits their ability to stop severe bleeding and can compromise healing.— Jianyu Li, McGill University
With a better clot, you can help to very quickly stop the bleeding. That is a life-saving kind of technology.— Jianyu Li, in interview with Global News
The Hearth Conversation Another angle on the story
Why does it matter that these clots are 13 times more resilient? What actually happens when a clot breaks?
When you're bleeding heavily, your body's natural clot is fragile—it can rupture under the pressure of blood flow or the stress of the wound itself. If it breaks, you're back to square one, losing more blood while your body tries again. A stronger clot holds the line.
And the speed difference—five minutes versus seconds—that seems like the real game-changer here.
It is. In trauma, you're racing against shock and organ failure. Every minute of uncontrolled bleeding is minutes closer to death. If you can seal a wound in seconds instead of five minutes, you've bought the patient time to get to surgery, to get transfusions, to survive.
The source mentions they tried shellfish-derived materials before. Why did that fail?
The clots were too weak, the cells broke down, and the chemical process created pollution. It was solving one problem by creating another. Click clotting works with what's already in the blood, so there's no foreign material to reject or contaminate.
How does this actually work chemically? What's the "click" part?
It's a chemical reaction that causes the blood components to bond together into a solid gel almost instantly. The name comes from the speed and precision of the reaction—it's like clicking pieces together rather than waiting for them to slowly bond.
If it takes 10 to 20 minutes to prepare, how is that faster than natural clotting?
The preparation happens before or immediately after injury. Once applied, it works in seconds. In a surgical setting, you can have it ready. In trauma, even 10 minutes of preparation is worth it if the clot then stops bleeding in seconds instead of five minutes.
What happens next? Is this going to hospitals soon?
That's the question. The research is published and the results are strong, but moving from the lab to clinical use takes time—trials, regulatory approval, training. But the potential is clear enough that this will likely move forward.